Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New digital assistant aims to stop post-surgery delirium in seniors

NCT ID NCT06445153

Prevention Sponsor: Charite University, Berlin, Germany Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a digital decision-support system (Digi-POD) to help prevent postoperative delirium in patients aged 70 and older having elective surgery. The system analyzes patient data and provides evidence-based recommendations to doctors, nurses, and families. Researchers will measure how well the tool improves guideline adherence and reduces delirium after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
digital clinical decision support system
What this could lead to
If successful, this could provide a practical tool to reduce postoperative delirium in older patients, improving recovery and hospital safety.
What could go wrong
This is an early-stage implementation study, not a drug trial. The tool's effectiveness depends on real-world use, and results may vary across hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

845 people

The number who actually took part.

Started

Jun 2024

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Study patients: Inclusion Criteria: * Age ≥ 70 years * Male and female patients * Patients who are insured through statutory health insurance * Patients capable of giving consent for inclusion: by the patient, preoperatively * Patients under guardianship for inclusion: written declaration of consent by guardian * Operation (elective) Exclusion Criteria: * Insufficient language skills * Moribund patients Study relatives Inclusion Criteria: * Age ≥ 18 years * Male and female relatives * Relatives capable of giving consent for inclusion Exclusion Criteria: * Insufficient language skills * No consent for data entry Substudy of the Charité - University Berlin: Inclusion criteria: \- All inpatients ≥ 18 years of age who have undergone delirium screening with a validated delirium screening instrument

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postoperative delirium are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emergence Delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postoperative delirium

Contacts and locations

Locations

  • CARITAS Klinik Maria Heimsuchung

    Berlin, Germany

  • Department of Anaesthesiolgy and Intensive Care Medicine CCM/CVK, Charite- University Berlin

    Berlin, 13355, Germany

  • Institut für Anästhesiologie und Schmerztherapie-Herz- und Diabeteszentrum NRW- Universitätsklinik der Ruhr-Universität Bochum

    Bad Oeynhausen, Bochum, 32545, Germany

  • Klinikum im Friedrichshain - Vivantes - Netzwerk für Gesundheit GmbH

    Berlin, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.